Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C287005-5mg | 5mg | In stock | $39.90 | |
C287005-10mg | 10mg | In stock | $64.90 | |
C287005-25mg | 25mg | In stock | $129.90 | |
C287005-50mg | 50mg | In stock | $205.90 | |
C287005-100mg | 100mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $314.90 |
Inhibits the MRTF/SRF gene transcription pathway; antifibrotic agent.
Synonyms | N-(4-Chlorophenyl)-1-[3-(2-furanyl)benzoyl]-3-piperidinecarboxamide;CCG-203971;N-(4-Chlorophenyl)-1-[3-(2-furanyl)benzoyl]-3-piperidinecarboxamide; CCG 203971, CCG-203971, CCG-203971 CCG 203971;CCG203971;N-(4-chlorophenyl)-1-(3-(furan-2-yl)benzoyl)piperid |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Antifibrotic agent; inhibits fibrosis by targeting the MRTF/SRF gene transcription pathway. Selectively inhibits proliferation of SSc-derived dermal fibroblasts but not that of normal fibroblasts. Inhibits expression of CTGF,α-SMA, and COL1A2 in SSc fibr |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(4-chlorophenyl)-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide |
---|---|
INCHI | InChI=1S/C23H21ClN2O3/c24-19-8-10-20(11-9-19)25-22(27)18-6-2-12-26(15-18)23(28)17-5-1-4-16(14-17)21-7-3-13-29-21/h1,3-5,7-11,13-14,18H,2,6,12,15H2,(H,25,27) |
InChi Key | HERLZBNILRVHQN-UHFFFAOYSA-N |
Canonical SMILES | C1CC(CN(C1)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl |
Isomeric SMILES | C1CC(CN(C1)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl |
PubChem CID | 71681561 |
MeSH Entry Terms | CCG-203971;N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide |
Molecular Weight | 408.88 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2209410 | Certificate of Analysis | Feb 09, 2022 | C287005 |
C2209411 | Certificate of Analysis | Feb 09, 2022 | C287005 |
C2209414 | Certificate of Analysis | Feb 09, 2022 | C287005 |
C2209415 | Certificate of Analysis | Feb 09, 2022 | C287005 |
C2209416 | Certificate of Analysis | Feb 09, 2022 | C287005 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 20.44, Max Conc. mM: 50 |
---|
1. Bell JL, Haak AJ, Wade SM, Kirchhoff PD, Neubig RR, Larsen SD. (2013) Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.. Bioorg Med Chem Lett, 23 (13): (3826-32). [PMID:23707258] |